• 1. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 2-(2',5-Difluorobiphenyl-2-yl)acetic acid (CAS No. 1214341-59-9)

2-(2',5-Difluorobiphenyl-2-yl)acetic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1214341-59-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of biphenyl derivatives, characterized by its unique structural motif involving two benzene rings connected at the ortho positions with fluorine substituents. The presence of these fluorine atoms introduces distinct electronic and steric properties, making this molecule a valuable scaffold for the development of novel bioactive agents.

The structure of 2-(2',5-Difluorobiphenyl-2-yl)acetic acid features a carboxylic acid functional group at one end of the biphenyl core, which is a common pharmacophore in drug design. The carboxylic acid moiety not only contributes to the molecule's solubility in polar solvents but also serves as a potential site for further chemical modifications, such as esterification or amidation, to enhance its pharmacological properties. The fluorinated biphenyl backbone provides rigidity and stability to the molecule while allowing for fine-tuning of its interactions with biological targets.

In recent years, there has been growing interest in fluorinated aromatic compounds due to their ability to modulate enzyme activity and receptor binding affinity. The fluorine atoms in 2',5-Difluorobiphenyl-2-yl)acetic acid can influence electronic distribution across the aromatic system, leading to enhanced binding interactions with proteins and nucleic acids. This property has been exploited in the design of kinase inhibitors, antibacterial agents, and anticancer drugs, where precise control over molecular interactions is crucial.

One of the most compelling aspects of 2-(2',5-Difluorobiphenyl-2-yl)acetic acid is its potential as a building block for structure-based drug design. Researchers have leveraged its scaffold to develop molecules with improved pharmacokinetic profiles and reduced toxicity. For instance, studies have demonstrated that derivatives of this compound exhibit potent activity against various therapeutic targets, including protein kinases involved in cancer signaling pathways. The fluorine atoms play a critical role in optimizing these interactions, often leading to higher selectivity and efficacy.

The synthesis of 2-(2',5-Difluorobiphenyl-2-yl)acetic acid presents unique challenges due to the sensitivity of the fluorinated aromatic ring. Advanced synthetic methodologies, such as cross-coupling reactions and palladium-catalyzed transformations, are typically employed to construct the biphenyl core with high precision. Recent advancements in synthetic chemistry have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications.

Recent publications have highlighted the utility of 2-(2',5-Difluorobiphenyl-2-yl)acetic acid in developing novel therapeutic agents. For example, researchers have reported on its use in creating small-molecule inhibitors targeting aberrant signaling pathways in diseases such as leukemia and breast cancer. The compound's ability to modulate protein-protein interactions has opened new avenues for drug discovery, particularly in the area of post-translational modifications that are often dysregulated in disease states.

The chemical properties of 2-(2',5-Difluorobiphenyl-2-yl)acetic acid also make it an attractive candidate for material science applications. Its rigid structure and electronic characteristics can be exploited in designing organic semiconductors and liquid crystals. These materials are essential components in electronic devices such as organic light-emitting diodes (OLEDs) and liquid crystal displays (LCDs). The presence of fluorine atoms can further enhance thermal stability and chemical resistance, making it suitable for demanding industrial environments.

In conclusion, 2-(2',5-Difluorobiphenyl-2-yl)acetic acid (CAS No. 1214341-59-9) represents a significant advancement in both pharmaceutical and materials science research. Its unique structural features, combined with its versatile reactivity, make it a valuable tool for developing innovative therapeutic agents and functional materials. As research continues to uncover new applications for this compound, its importance in addressing global health challenges and technological needs is likely to grow.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)